Linde plc (LIN)
NASDAQMaterialsSpecialty ChemicalsSnapshot 2026-07-07
$538.23-0.42%
Close 2026-07-07 · 1-day change
Reading LIN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LIN free→NASDAQMaterialsSpecialty ChemicalsSnapshot 2026-07-07
Reading LIN? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track LIN free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This is a durable compounder with a focus on steady earnings growth. The current thesis state is intact, supported by strong recent financial performance, although the sector backdrop presents challenges.
The market appears to be pricing in a premium valuation, reflecting expectations for continued earnings growth. However, this premium may be unjustified given the mixed execution quality and recent changes in sentiment.
Management is on track to achieve its EPS growth targets for 2026, with recent results showing positive momentum. However, there is a moderate risk of missing expectations, as the company has struggled with execution in the past.
The thesis hinges on the performance of sector bellwethers like SHW, ECL, and APD. If these companies continue to perform well, it could support LIN's growth. Conversely, any negative guidance from these peers could adversely affect LIN's outlook.
Overall, LIN's performance is currently strong, but it faces risks from sector dynamics and execution challenges. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat and positive growth prospects have reinforced the outlook for the company. There are no significant threats currently impacting the thesis.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: This range shows if Linde is on track to meet its 8% to 10% growth target. Strong EPS growth signals good performance.
Confirms:Q2 adjusted EPS reported at $4.40 or higher.
Disproves:Q2 adjusted EPS reported below $4.40.
Why it matters: This growth shows Linde can make money. It helps build investor trust.
Confirms:Full-year adjusted EPS reported at $17.60 or higher.
Disproves:Full-year adjusted EPS was below $17.60.
Why it matters: Higher sales growth shows strong demand and good pricing strategies.
Confirms:Q2 underlying sales growth exceeds 3% year over year.
Disproves:Q2 sales growth is below 3%. This shows weak demand.
Why it matters: This range shows Linde's commitment to growth and maintenance. Meeting this target supports future revenue.
Confirms:Q2 capital spending was $1.5 billion or more.
Disproves:Q2 capital spending was below $1.5 billion.
Why it matters: A rise in sector revenue growth may mean a recovery for Linde.
Confirms one read:Sector revenue growth turns positive after being negative for three years.
Confirms the other:Sector revenue growth stays negative, showing ongoing decline.
Why it matters: A growing project backlog shows that future revenue may be strong.
Confirms:Project backlog is above $10 billion, showing strong future demand.
Disproves:Project backlog is below $10 billion. This shows possible revenue challenges.